CNS Pharmaceuticals, Inc.
SEC CIK 1729427 · CNSP · last insider filing 2026-05-20
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Charles Faith L. | Director | filed 2023 - 2026 |
| Levin Rami | Director · CEO and President | filed 2026 - 2026 |
| Climaco John M | Director · Chief Executive Officer | filed 2019 - 2025 |
| Keyes Jeffry R. | Director | filed 2019 - 2025 |
| Gumulka Jerzy | Director | filed 2019 - 2025 |
| Cockroft Bettina M. | Director | filed 2023 - 2025 |
| Mahery Amy | Director | filed 2024 - 2025 |
| Evans Carl Anthony | Director | filed 2019 - 2024 |
| Andraczke Andrzej | Director | filed 2019 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| O'Loughlin Steve | Chief Financial Officer | filed 2026 - 2026 |
| Faulkner Eric | Chief Technology Officer | filed 2026 - 2026 |
| Downs Christopher | Chief Financial Officer | filed 2019 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.